Clinical Trial Details

EORTC-30974

Back to Clinical Trials Database

A ranomized phase III study of sequential high-dose Cisplatinum/Etoposide/Ifosfamide plus stem cell support versus BEP in patients with poor prognosis Germ Cell Cancer

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 28-Apr-1999
Date Step1 close: 18-Jun-2007
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 222
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/NCT00003941
NCT number NCT00003941